Cargando…
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Few therapies are currently available for patients with KRAS-driven cancers, highlighting the need to identify new molecular targets that modulate central downstream effector pathways. Here we found that the microRNA (miRNA) cluster including miR181ab1 is a key modulator of KRAS-driven oncogenesis....
Autores principales: | Valencia, Karmele, Erice, Oihane, Kostyrko, Kaja, Hausmann, Simone, Guruceaga, Elizabeth, Tathireddy, Anuradha, Flores, Natasha M., Sayles, Leanne C., Lee, Alex G., Fragoso, Rita, Sun, Tian-Qiang, Vallejo, Adrian, Roman, Marta, Entrialgo-Cadierno, Rodrigo, Migueliz, Itziar, Razquin, Nerea, Fortes, Puri, Lecanda, Fernando, Lu, Jun, Ponz-Sarvise, Mariano, Chen, Chang-Zheng, Mazur, Pawel K., Sweet-Cordero, E. Alejandro, Vicent, Silvestre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108928/ https://www.ncbi.nlm.nih.gov/pubmed/31874105 http://dx.doi.org/10.1172/JCI129012 |
Ejemplares similares
-
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
por: Erice, Oihane, et al.
Publicado: (2019) -
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
por: Vallejo, Adrian, et al.
Publicado: (2017) -
Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
por: Entrialgo‑Cadierno, Rodrigo, et al.
Publicado: (2023) -
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
por: Entrialgo-Cadierno, Rodrigo, et al.
Publicado: (2023) -
PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem?
por: Narayanan, Shruthi, et al.
Publicado: (2021)